{"abstract":"The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2023/12/18/2023-27652.html","cfr_references":[],"citation":"88 FR 87431","comment_url":null,"comments_close_on":"2024-01-17","correction_of":null,"corrections":[],"dates":"Submit written comments (including recommendations) on the collection of information by January 17, 2024.","disposition_notes":null,"docket_ids":["Docket No. FDA-2023-N-0795"],"dockets":[{"supporting_documents":[{"title":"Reference 7 - Shengchao-s12874-017-0353-1 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","document_id":"FDA-2023-N-0795-0004"},{"title":"Reference 3 - Cheung - s12874-019-0786-9 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","document_id":"FDA-2023-N-0795-0003"},{"title":"Reference 1 - Sullivan - nihms-819225 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","document_id":"FDA-2023-N-0795-0002"}],"agency_name":"FDA","documents":[{"comment_count":1,"comment_start_date":"2023-12-18","updated_at":"2024-01-18T00:06:40.929-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2023-N-0795-0007","allow_late_comments":null,"id":"FDA-2023-N-0795-0007","comment_end_date":"2024-01-18","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":3,"id":"FDA-2023-N-0795","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising"}],"document_number":"2023-27652","effective_on":null,"end_page":87433,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2023/12/18/2023-27652.xml","html_url":"https://www.federalregister.gov/documents/2023/12/18/2023-27652/agency-information-collection-activities-submission-for-office-of-management-and-budget-review","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2023-27652?publication_date=2023-12-18","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2023-12-18/2023-27652/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":181,"last_updated":"2026-04-04 08:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-12-18/pdf/2023-27652.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-27652.pdf?1702647916","publication_date":"2023-12-18","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2023/12/18/2023-27652.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Reference 7 - Shengchao-s12874-017-0353-1 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","document_id":"FDA-2023-N-0795-0004"},{"title":"Reference 3 - Cheung - s12874-019-0786-9 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","document_id":"FDA-2023-N-0795-0003"},{"title":"Reference 1 - Sullivan - nihms-819225 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","document_id":"FDA-2023-N-0795-0002"}],"comments_count":1,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2023-N-0795","supporting_documents_count":3,"docket_id":"FDA-2023-N-0795","document_id":"FDA-2023-N-0795-0007","regulation_id_number":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","checked_regulationsdotgov_at":"2024-01-18T05:06:40Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":87431,"subtype":null,"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","toc_doc":"A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising","toc_subject":"Agency Information Collection Activities; Proposals, Submissions, and Approvals:\n","topics":[],"type":"Notice","volume":88}